As we move further into earnings season we are starting to see some of the reports from mining stocks, and it is still a messy picture. If you make your money digging stuff out of the ground, you’re having a pretty tough go of it in 2014.
Best Cheap Companies To Own For 2016: PowerShares International Dividend Achievers Portfolio (PID)
PowerShares International Dividend Achievers Portfolio (the Fund) seeks to replicate, before fees and expenses, the International Dividend Achievers Index (the Index). The Fund invests in sectors, including financials, utilities, consumer staples, commercial banks, insurance, utilities and information technology. PowerShares Capital Management LLC is the adviser of the Fund.
The Index seeks to identify an international group of American Depository Receipts that have qualified as International Dividend Achievers. The Index is designed to track the performance of dividend paying American Depository Receipts and non-United States common or ordinary stocks trading on the NYSE, NADDAQ or AMEX.
Advisors' Opinion:- [By Carlton Delfeld]
Second, add to the mix, one of my long-time favorite ETFs, the PowerShares International Dividend Achievers (PID).
To get into this exclusive basket, companies have to have a record of increasing dividends for five consecutive years. The United Kingdom and Canada make up 50% of its holdings with the US at only 6%.
- [By Editor , DividendChannel.com]
According to the ETF Finder at ETF Channel, Enbridge stock is an underlying holding representing 1.97% of the Powershares International Dividend Achievers ETF (PID), which holds $20,709,837 worth of ENB shares.
Top 5 Regional Bank Stocks To Watch Right Now: Alexza Pharmaceuticals Inc.(ALXA)
Alexza Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, and commercialization of novel proprietary products for the acute treatment of central nervous system conditions worldwide. Its product candidates are based on a proprietary technology, the Staccato system, which vaporizes an excipient-free drug to form a condensation aerosol that, when inhaled, allows for rapid systemic drug delivery. The company?s lead product candidate includes ADASUVE (Staccato loxapine) for the acute treatment of agitation in adults with schizophrenia or bipolar disorder. Its other product candidates under development comprise AZ-007 (Staccato zaleplon), which has completed Phase I clinical trials for the treatment of insomnia; and Staccato nicotine that is in pre-Phase 1 clinical trials to help smokers quit by addressing both the chemical and behavioral components of nicotine addiction by delivering nicotine replacement through inhalation. The company was f ormerly known as Alexza Molecular Delivery Corporation and changed its name to Alexza Pharmaceuticals, Inc. in July 2005. Alexza Pharmaceuticals, Inc. was founded in 2000 and is headquartered in Mountain View, California.
Advisors' Opinion:- [By Roberto Pedone]
Another under-$10 stock that's starting to move within range of triggering a big breakout trade is Alexza Pharmaceuticals (ALXA), which is focused on the research, development and commercialization of novel proprietary products for the acute treatment of central nervous system conditions. This stock hasn't done much so far in 2013, with shares up by just 5.6%.
If you take a look at the chart for Alexza Pharmaceuticals, you'll notice that this stock has been uptrending strong for the last month, with shares moving higher from its low of $4.23 to its recent high of $5.52 a share. Following that uptrend, shares of ALXA have now started to trend sideways and consolidate between $4.95 on the downside and $5.52 on the upside. Shares of ALXA are now starting to spike within range of triggering a big breakout trade above the upper-end of its recent sideways trading chart pattern.
Market players should now look for long-biased trades in ALXA if it manages to break out above some near-term overhead resistance levels at $5.40 to $5.52 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 256,570 shares. If that breakout triggers soon, then ALXA will set up to re-test or possibly take out its 52-week high at $6.65 a share, or its next major overhead resistance level at $7.60 a share.
Traders can look to buy ALXA off weakness to anticipate that breakout and simply use a stop that sits right below its 50-day moving average at $4.77 a share, or near its 200-day moving average at $4.63 a share. One can also buy ALXA off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
- [By Monica Wolfe]
Alexza Pharmaceuticals (ALXA)
As Alexza Pharmaceuticals��price has continued to stay at a 10-year low price, President and CEO Thomas King decided to increase his holdings in the company.
- [By Roberto Pedone]
Alexza Pharmaceuticals (ALXA) is a pharmaceutical company focused on the research, development and commercialization of novel proprietary products for the acute treatment of central nervous system conditions. This stock closed up 1.9% to $4.63 in Tuesday's trading session.
Tuesday's Range: $4.51-$4.73
52-Week Range: $2.91-$6.65
Tuesday's Volume: 509,000
Three-Month Average Volume: 421,914From a technical perspective, ALXA trended modestly higher here right off its 50-day moving average at $4.48 with above-average volume. This move is quickly moving shares of ALXA within range of triggering a major breakout trade. That trade will hit if ALXA manages to take out some near-term overhead resistance levels at $4.80 to $4.86 and then once it clears more resistance at $5.20 with high volume.
Traders should now look for long-biased trades in ALXA as long as it's trending above its 50-day at $4.48 or above more support at $4.20 and then once it sustains a move or close above those breakout levels with volume that hits near or above 421,914 shares. If that breakout triggers soon, then ALXA will set up to re-test or possibly take out its 52-week high at $6.65.
Top 5 Regional Bank Stocks To Watch Right Now: Ashford Hospitality Trust Inc (AHT)
Ashford Hospitality Trust, Inc. is a publicly owned real estate investment trust. The firm engages in investment and management of properties in the hospitality industry. It invests in the real estate markets of the United States. The firm primarily invests in hotels with a focus on the ownership of upper-upscale and upscale full-service and select service hotels in primary, secondary and resort markets. It also invests in mid-scale and luxury hotels. The firm invests across all segments and at all levels of the capital structure, including direct hotel investments, first mortgages, mezzanine loans, construction loans, and sale-leaseback transactions. It primarily concentrates among Marriott, Hilton, Hyatt, and Starwood brands. Ashford Hospitality Trust, Inc. was founded in 1968 and is based in Dallas, Texas.
Advisors' Opinion:- [By Jake L'Ecuyer]
Among the financial stocks, Ashford Hospitality Trust (NYSE: AHT) was down more than 5.7 percent, while The Central Europe, Russia and Turkey Fund (NYSE: CEE) tumbled around 5 percent.
- [By Lawrence Meyers]
Finally, we have a long-time holding of my own portfolio, Ashford Hospitality Trust Preferred D Shares (AHT), which is an 8.45% issuance trading right about par.� With hotel preferred stock, you have a great opportunity for safe yields.� Your preferred stock is paid dividends before common shareholders receive theirs.� During the financial crisis, when every other hotel stock was getting destroyed and cutting �both common and preferred dividends, Ashford maintained its preferred payouts.� It is the hotel REIT with the highest insider ownership, and has a solid balance sheet that survived the worst of times.
Top 5 Regional Bank Stocks To Watch Right Now: ePlus Inc.(PLUS)
ePlus inc., through its subsidiaries, engages in selling, leasing, financing, and managing information technology (IT) and other assets in the United States. Its Technology Sales segment involves in the direct marketing of IT equipment and third-party software solutions of Cisco Systems, HP, VMWare, NetApp, IBM, and Microsoft; and the provision of proprietary software for enterprise supply management, including order-entry and order-management, procurement, spend management, asset management, document management, distribution, and electronic catalog content management software and services. This segment also provides professional technology services in the areas of data center, storage, security, cloud enablement, and IT infrastructure that cover Internet telephony and communications, collaboration, cloud computing, virtual desktop infrastructure, network design and implementation, storage, security, virtualization, business continuity, visual communications, audio/visual technologies, maintenance, and implementation services. The company?s Financing segment offers a range of leasing and financing options for IT and capital assets, such as computers, associated accessories and software, communication-related equipment, medical equipment, industrial machinery and equipment, office furniture and general office equipment, transportation equipment, and other general business equipment. It also leases and finances equipment, as well as supplies software and services directly and through relationships with vendors and equipment manufacturers. ePlus sells its products primarily through direct sales force, inside sales representatives, and business development associates to commercial customers; federal, state, and local governments; K-12 schools; and higher education institutions. The company was formerly known as MLC Holdings, Inc. and changed its name to ePlus inc. in 1999. ePlus was founded in 1990 and is headquartered in Herndon, Virginia.
Advisors' Opinion:- [By alicet236]
ePlus Inc. (PLUS): President and CEO, 10% Owner Phillip G. Norton Sold 198,730 Shares
President and CEO, 10% Owner of ePlus Inc. (PLUS) Phillip G. Norton sold 198,730 shares on 05/05/2014 at an average price of $47.5. ePlus Inc. was founded in 1990 and is a Delaware corporation and began using the name ePlus inc. ePlus Inc. has a market cap of $401.106 million; its shares were traded at around $49.74 with a P/E ratio of 11.50 and P/S ratio of 0.38. ePlus Inc. had an annual average earnings growth of 6.70% over the past 10 years. GuruFocus rated ePlus Inc.�the business predictability rank of 2-star.
- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on ePlus inc. (Nasdaq: PLUS ) , whose recent revenue and earnings are plotted below.
No comments:
Post a Comment